These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29088451)

  • 61. [How I explore ... the skin functional involvement in scleroderma].
    Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
    Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ultrastructure of cutaneous cellular infiltrates in scleroderma.
    Fleischmajer R; Perlish JS; West WP
    Arch Dermatol; 1977 Dec; 113(12):1661-6. PubMed ID: 202203
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Generalized morphea associated with vascular lesions--comparison with diffuse scleroderma (author's transl)].
    Kurachi N; Ohashi M; Maruta H; Tuda S
    Nihon Hifuka Gakkai Zasshi; 1976 Jul; 86(8):465-71. PubMed ID: 987389
    [No Abstract]   [Full Text] [Related]  

  • 64. [Generalized morphea-like progressive systemic sclerosis with anticentromere antibodies and eosinophilic cellulitis].
    Sasaki T; Nakajima H; Kameda Y
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):469-76. PubMed ID: 2614990
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized scleroderma.
    Arnett FC; Tan FK; Uziel Y; Laxer RM; Krafchik BR; Antohi S; Bona C
    Arthritis Rheum; 1999 Dec; 42(12):2656-9. PubMed ID: 10616014
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
    Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
    J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Arch Dermatol Res; 1995; 287(2):193-7. PubMed ID: 7763091
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Immunogenetic studies of familial occurrence of progressive systemic scleroderma and circumscribed scleroderma].
    Holzmann H; Schlieter A; Altmeyer P; Kühnl P
    Hautarzt; 1992 Sep; 43(9):548-53. PubMed ID: 1399599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cutaneous fibrinolytic activity in scleroderma.
    Lotti T; Cerinic MM; Marmugi D; Fabbri P
    Clin Exp Rheumatol; 1985; 3(3):249-53. PubMed ID: 4053443
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
    Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
    Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cyclosporin in localized and systemic scleroderma--a clinical study.
    Wörle B; Hein R; Krieg T; Meurer M
    Dermatologica; 1990; 181(3):215-20. PubMed ID: 2269381
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Yoshizaki A; Miyazaki M; Tamaki Z; Sato S
    J Dermatol; 2016 Jul; 43(7):808-10. PubMed ID: 26876001
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.
    Falkner D; Wilson J; Medsger TA; Morel PA
    Arthritis Rheum; 1998 Jan; 41(1):74-80. PubMed ID: 9433872
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diffuse alveolar haemorrhage in a case with anti-RNA polymerase III antibody-positive systemic sclerosis successfully treated with plasma exchange and corticosteroid therapy.
    Asai A; Banno S; Asai N; Ito M; Sugiyama H; Yamaguchi M; Iwagaitsu S; Nobata H; Kinasi H; Katsuno T; Ito Y
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):51-55. PubMed ID: 33086969
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nodular scleroderma in a worker using a silica-containing abrasive.
    Yamamoto T; Furuse Y; Katayama I; Nishioka K
    J Dermatol; 1994 Oct; 21(10):751-4. PubMed ID: 7798433
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Localized and systemic forms of scleroderma in adults and children .
    Atzeni F; Bardoni A; Cutolo M; Hunzelmann N; Krieg T; Martini G; Montecucco C; Olski TM; Secchi ME; Valentini G; Zulian F; Sarzi-Puttini P
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S36-45. PubMed ID: 16466623
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
    Chang WS; Schollum J; White DH; Solanki KK
    Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.